children novel coronavirus pneumonia (COVID-19) (mild)
Conditions
Interventions
Experimental group:Chinese medicine paste
Control group:Chinese medicine patch with placebo
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for novel coronavirus pneumonia (mild) or be diagnosed with novel coronavirus pneumonia (mild); 2. Aged range from 3 to 14 years (inclusive); 3. Body temperature >=37.3? (the body temperature in the consulting room on the day of treatment and the highest body temperature within 2 hours shall be considered); 4. No more than 48 hours have passed since the first onset of symptoms (or confirmed onset of illness); 5. Agreed to participate in the study, and the children's families/children signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Bacterial, fungal and other infections other than COVID-19 infection; 2. Patients with bronchial asthma, bacterial pneumonia, bronchitis, tuberculosis and other respiratory diseases; 3. History of febrile convulsions; 4. Patients with diabetes, tumor, liver, kidney, blood system and other serious diseases; 5. Patients with mental diseases; 6. Participate in other clinical studies within 30 days prior to the screening period; 7. Allergic constitution or allergy to known research drug ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time for complete remission of fever; | — |
Secondary
| Measure | Time frame |
|---|---|
| Antipyretic onset time;Emergency antipyretic drugs (acetaminophen) usage;Individual symptom score 3 and 5 days after treatment;Adverse drug reaction; | — |
Countries
China
Contacts
Public ContactJi Xiaohua
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed